Al Kharousi Nadiya, Alnaabi Khalfan Salim Khalfan, Almahrouqi Omar, Mal Washoo
Department of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman.
Department of Ophthalmology, College of Medicine and Health Science, Muscat, Oman.
Oman J Ophthalmol. 2022 Nov 2;15(3):269-273. doi: 10.4103/ojo.ojo_68_22. eCollection 2022 Sep-Dec.
This study aimed to evaluate the visual outcomes and associated factors in Omani patients with Behcet's disease (BD).
This is a descriptive retrospective analytical cohort study. All Omani patients of age 5-65 years with a confirmed clinical diagnosis of BD having ocular manifestation who attended the Rheumatology and Ophthalmology clinics at Sultan Qaboos University Hospital, Oman from January 2018 to October 2020. The demographic data, clinical findings, systemic, and ocular examination of all the recruited patients were retrieved from the electronic patient record.
The study included 31 male and 16 female participants. The median age is 29.7 ± 10.6 years. Most patients with ocular manifestations presented in the third decade of their life (21-30 years' age). The most common ocular manifestations in our study were uveitis (91.5%) followed by vitritis (40.4%), and retinal vasculitis (36.2%). The most common ocular complications in order of frequency were cataract (27.7%), posterior synechiae (23.4%), and cystoid macular edema (21.2%). In this study, 22.7% of the patients with BD-related ocular manifestations reported severe visual loss. In addition, when adding the patients with severe visual loss secondary to complications such as secondary glaucoma and optic nerve atrophy, the severe visual loss cumulatively reported being 50% for both groups.
The clinical characteristics of ocular manifestations in BD in Oman are similar to data from studies that have been conducted in other countries. However, our study found that the severity of ocular manifestations was more dominant among females. This study finding can be helpful for clinicians to predict ocular manifestations of BD to plan a timely follow-up and subsequently prevent further severe complications or visual loss.
本研究旨在评估阿曼白塞病(BD)患者的视力预后及相关因素。
这是一项描述性回顾性分析队列研究。纳入2018年1月至2020年10月期间在阿曼苏丹卡布斯大学医院风湿科和眼科门诊就诊、年龄在5至65岁之间、临床确诊为BD且有眼部表现的所有阿曼患者。从电子病历中检索所有入选患者的人口统计学数据、临床发现、全身及眼部检查结果。
该研究纳入了31名男性和16名女性参与者。中位年龄为29.7±10.6岁。大多数有眼部表现的患者在其生命的第三个十年(21 - 30岁)出现症状。本研究中最常见的眼部表现为葡萄膜炎(91.5%),其次是玻璃体炎(40.4%)和视网膜血管炎(36.2%)。按发生频率排序,最常见的眼部并发症为白内障(27.7%)、虹膜后粘连(23.4%)和黄斑囊样水肿(21.2%)。在本研究中,22.7%有BD相关眼部表现的患者报告有严重视力丧失。此外,将继发于继发性青光眼和视神经萎缩等并发症导致严重视力丧失的患者计算在内,两组累计严重视力丧失报告率为50%。
阿曼BD患者眼部表现的临床特征与其他国家开展的研究数据相似。然而,我们的研究发现眼部表现的严重程度在女性中更为突出。这一研究结果有助于临床医生预测BD的眼部表现,以便及时安排随访,进而预防进一步的严重并发症或视力丧失。